Last $7.98 USD
Change Today +0.135 / 1.72%
Volume 12.8K
As of 10:44 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

medgenics inc (MDGN) Key Developments

Medgenics, Inc. Announces Audited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Medgenics, Inc. announced audited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported a loss of $6.20 million or $0.30 per share, compared with a loss of $5.21 million or $0.28 per share for the comparative quarter in 2013. For the period, the company reported operating loss of $12,628,000 against $17,818,000 a year ago. Loss before taxes on income was $15,052,000 against $17,112,000 a year ago. Loss was $15,071,000 or $1.37 per diluted share against $17,129,000 or $1.06 per diluted share a year ago.

Medgenics, Inc., Q4 2014 Earnings Call, Feb 13, 2015

Medgenics, Inc., Q4 2014 Earnings Call, Feb 13, 2015

Medgenics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 05:00 PM

Medgenics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 05:00 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Michael F. Cola, Chief Executive Officer, President and Director.

Medgenics Seeks Acquisitions

Medgenics, Inc. (AMEX:MDGN) has completed a Follow-on Equity Offering in the amount of $21.01 million. Medgenics said, "We intend to use the net proceeds from this offering for product development activities, including clinical trials for our most advanced product candidates and investigation of new applications for our technologies; for patent maintenance fees and intellectual property support; for licensing and research collaborations, including the research collaboration with the Children’s Hospital of Philadelphia; and for general corporate purposes and working capital, which may include the acquisitions or licensing of complementary technologies, products or businesses."

Medgenics, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:00 PM

Medgenics, Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:00 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Michael F. Cola, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGN:US $7.98 USD +0.135

MDGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGN.
View Industry Companies
 

Industry Analysis

MDGN

Industry Average

Valuation MDGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDGENICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.